Pierre Fabre Pharmaceuticals, Inc. today announced the transfer of the Investigational New Drug Application for tabelecleucel ...

Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...

A south of Butser school community is in mourning following the death of two Year 9 students in two separate unconnected ...

NMDPSM, a global nonprofit leader in cell therapy, and its collaborative research program, CIBMTR (Center for International ...